Regionalized Vaccine Manufacturing Collaborative Revenue

Research Services • London, England, United Kingdom • 1-10 Employees

Regionalized Vaccine Manufacturing Collaborative revenue & valuation

Annual revenue	$598,885
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Research Services industry and current estimated revenues	$2,000,000
Total funding	No funding

Key Contacts at Regionalized Vaccine Manufacturing Collaborative

Frederik Kristensen

Managing Director

Michael Lusiola

Director

Company overview

Headquarters	4-5 Langham Place, Henry Wood House, London, England W1B 3DG, GB
Website	rvmc.net
NAICS	5417
Founded	2024
Employees	1-10

About Regionalized Vaccine Manufacturing Collaborative

RVMC is uniquely dedicated to establishing regional vaccine manufacturing and supply chain networks to improve vaccine equity and health security for all.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Manager

C-Suite

Director

Employees by Department

Regionalized Vaccine Manufacturing Collaborative has 4 employees across 4 departments.

Departments

Number of employees

Funding Data

Regionalized Vaccine Manufacturing Collaborative has never raised funding before.

Regionalized Vaccine Manufacturing Collaborative Tech Stack

Discover the technologies and tools that power Regionalized Vaccine Manufacturing Collaborative's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Tag Manager

Tag managers

Azure

PaaS

Radix UI

UI frameworks

Azure Front Door

Load balancers

HSTS

Security

Open Graph

Miscellaneous

React

JavaScript frameworks

Google Analytics

Analytics

Gatsby

JavaScript frameworks

Webpack

Miscellaneous

Microsoft 365

Frequently asked questions

Regionalized Vaccine Manufacturing Collaborative is located in London, England, GB.

Regionalized Vaccine Manufacturing Collaborative generates an estimated annual revenue of $598,885. This revenue figure reflects the company's market position and business performance in its industry.

Regionalized Vaccine Manufacturing Collaborative has an estimated valuation of $2,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Regionalized Vaccine Manufacturing Collaborative was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.

Regionalized Vaccine Manufacturing Collaborative has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contacts at Regionalized Vaccine Manufacturing Collaborative

Frederik Kristensen

Managing Director

Michael Lusiola

Director

4.8

40,000 users